Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 4/20 | 0.58 |
| ▸ | CYCS | P99999 | 3/20 | 0.56 |
| ▸ | TERT | O14746 | 5/20 | 0.55 |
| ▸ | STAT3 | P40763 | 1/20 | 0.54 |
| ▸ | STAT1 | P42224 | 1/20 | 0.54 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.51 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3912287 | 1.00 | TOP1 (0.58) | TOP1CYCSTERTSTAT3STAT1 | |
| SCHEMBL3912280 | 1.00 | TOP1 (0.58) | TOP1CYCSTERTSTAT3STAT1 | |
| SCHEMBL3913643 | 1.00 | TOP1 (0.58) | TOP1CYCSTERTSTAT3STAT1 | |
| SCHEMBL29693624 | 0.93 | TERT (0.62) | TOP1CYCSTERTENPP2ABCG2 | |
| SCHEMBL242168 | 0.93 | TERT (0.62) | TOP1CYCSTERTENPP2ABCG2 | |
| SCHEMBL6883584 | 0.93 | TOP1 (0.51) | TOP1CYCSTERTSTAT3STAT1 | |
| SCHEMBL25407804 | 0.91 | TERT (0.65) | TOP1CYCSTERTENPP2ABCG2 | |
| SCHEMBL31182124 | 0.91 | TERT (0.60) | TOP1CYCSTERTENPP2ABCG2 | |
| SCHEMBL31040346 | 0.91 | TERT (0.60) | TOP1CYCSTERTENPP2ABCG2 | |
| SCHEMBL31375135 | 0.91 | TERT (0.60) | TOP1CYCSTERTENPP2ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11518888-B2 | Color material dispersion liquid, composition, film, optical filter and display device | DAI NIPPON PRINTING CO., LTD. (JP) | 2022-12-06 | — | — | US | disclosed |
| US-11027017-B2 | PCI method for generating immune respose to antigenic molecule using checkpoint inhibitor and TLR3 ligand | PCI BIOTECH AS (NO) | 2021-06-08 | — | — | US | disclosed |
| US-20190352511-A1 | LANTHANIDE COMPLEXES COMPRISING DENDRIMERS | UNIVERSITE D'ORLEANS (FR) | 2019-11-21 | — | — | US | disclosed |
| WO-2018130542-A1 | LANTHANIDE COMPLEXES COMPRISING DENDRIMERS | UNIVERSITE D'ORLEANS (FR) | 2018-07-19 | — | — | WO | disclosed |
| US-9901636-B2 | Conjugate of a photosensitiser and chitosan and uses thereof | PCI BIOTECH AS (NO) | 2018-02-27 | — | — | US | disclosed |
| US-20180050105-A1 | METHOD | PCI BIOTECH AS (NO) | 2018-02-22 | — | — | US | disclosed |
| US-20170252441-A1 | COMPOUND AND METHOD | PCI BIOTECH AS (NO) | 2017-09-07 | — | — | US | disclosed |
| US-9691999-B2 | Photoelectric conversion device vapor deposition material, photoelectric conversion device, sensor, and imaging device | FUJIFILM CORPORATION (JP) | 2017-06-27 | — | — | US | disclosed |
| US-9691999-B2 | Photoelectric conversion device vapor deposition material, photoelectric conversion device, sensor, and imaging device | FUJIFILM CORPORATION (JP) | 2017-06-27 | — | — | US | disclosed |
| US-9346768-B2 | Molecular glasses with functionalizable groups | HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE MINISTER OF NATIONAL DEFENSE (CA) | 2016-05-24 | — | — | US | disclosed |
| US-20140138522-A1 | PHOTOELECTRIC CONVERSION DEVICE VAPOR DEPOSITION MATERIAL, PHOTOELECTRIC CONVERSION DEVICE, SENSOR, AND IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2014-05-22 | — | — | US | disclosed |
| US-20140138522-A1 | PHOTOELECTRIC CONVERSION DEVICE VAPOR DEPOSITION MATERIAL, PHOTOELECTRIC CONVERSION DEVICE, SENSOR, AND IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2014-05-22 | — | — | US | disclosed |
| US-20120034670-A1 | ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME | NATIONAL UNIVERSITY CORPORATION OKAYAMA UNIVERSITY (JP) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180050105-A1 | METHOD | CD274, ICOS, CD47 | TOP1 1290/4885CYCS 4733/4885TERT 707/4885 |
| US-20120034670-A1 | ORGANIC-INORGANIC COMPOSITE MATERIAL AND PROCESS FOR PRODUCING SAME | RIOX2, MAOA, FTO | TOP1 3324/4885CYCS 2816/4885TERT 123/4885 |
| US-20170252441-A1 | COMPOUND AND METHOD | CSF3R, IL2, IL5 | TOP1 2013/4885CYCS 2836/4885TERT 3202/4885 |
| US-20190352511-A1 | LANTHANIDE COMPLEXES COMPRISING DENDRIMERS | CLTA, CLTB, CA12 | TOP1 2940/4885CYCS 995/4885TERT 2403/4885 |
| US-11027017-B2 | PCI method for generating immune respose to antigenic molecule using checkpoint inhibitor and TLR3 ligand | TLR3, TLR9, TLR6 | TOP1 2612/4885CYCS 4813/4885TERT 2019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.